# To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given With an Experimental Injection Catheter

> **NCT00090714** · PHASE2 · UNKNOWN · sponsor: **Corautus Genetics** · enrollment: 404 (—)

## Conditions studied

- Angina Pectoris

## Interventions

- **GENETIC:** pVGI.1(VEGF2)

## Key facts

- **NCT ID:** NCT00090714
- **Lead sponsor:** Corautus Genetics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 404 (—)
- **Last updated:** 2006-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00090714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00090714, "To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given With an Experimental Injection Catheter". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00090714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*